SCHEMBL7480869

SCHEMBL7480869

O=C(C=Cc1ccccc1)Nc1nnc(NCCN2CCOCC2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.54
HDAC1 Q13547 5/20 0.52
HDAC8 Q9BY41 5/20 0.52
HDAC6 Q9UBN7 5/20 0.52
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
HSP90AA1 P07900 1/20 0.52
ALDH1A1 P00352 5/20 0.50
LMNA P02545 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
GSK3B P49841 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7480861 1.00 RAB9A (0.54) RAB9AHDAC1HDAC8HDAC6HDAC3
SCHEMBL7480451 0.91 HSP90AA1 (0.49) RAB9AHSP90AA1ALDH1A1LMNAKMT2A
SCHEMBL7480459 0.91 HSP90AA1 (0.49) RAB9AHSP90AA1ALDH1A1LMNAKMT2A
SCHEMBL7488527 0.79 FSCN1 (0.52) RAB9AHDAC1HDAC8HDAC6HDAC3
SCHEMBL7480813 0.79 MMP1 (0.55) RAB9AHDAC1ALDH1A1LMNAKMT2A
SCHEMBL7488537 0.79 FSCN1 (0.52) RAB9AHDAC1HDAC8HDAC6HDAC3
SCHEMBL7480810 0.79 MMP1 (0.55) RAB9AHDAC1ALDH1A1LMNAKMT2A
SCHEMBL7481131 0.78 MMP1 (0.58) RAB9AHDAC4ALDH1A1LMNACYP3A4
SCHEMBL7481144 0.78 MMP1 (0.58) RAB9AHDAC4ALDH1A1LMNACYP3A4
SCHEMBL7484285 0.77 CYP3A4 (0.53) RAB9AHDAC1HDAC8HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP claimed
US-6150385-A VIRICIDE WITH ACTIVITY AGAINST CYTOMEGALO VIRUS (CMV), HERPES VIRUS INCLUDING VARICELLA ZOSTER VIRUS, THE EPSTEIN-BARR VIRUS, THE HERPES SIMPLEX VIRUS, AND THE HUMAN HERPES VIRUS TYPE 8 (HHV-8) PHARMACIA & UPJOHN COMPANY (US) 2000-11-21 US claimed
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP disclosed